Neuroimaging of stroke-like episodes in MELAS

Brain and Development

Volumn 33, Issue 4, 2011, Pages 283-288

  Ito, Hiromichi ^a,b   Mori, Kenji ^a   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Kaisei General Hospital   (Japan)

Author keywords

1H MRS; Diffusion weighted imaging; Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS); PET; SPECT

Indexed keywords

LACTIC ACID; N ACETYLASPARTIC ACID;

BRAIN HEMORRHAGE; BRAIN MITOCHONDRION; BRAIN PERFUSION; CINGULATE GYRUS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; MELAS SYNDROME; NEUROIMAGING; NEUROPATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

ANIMALS; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELAS SYNDROME; POSITRON-EMISSION TOMOGRAPHY; STROKE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 78650084651     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.06.010     Document Type: Review

References (53)

1. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481-488.
2. Iizuka T., Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res 2005, 2:29-45.
3. Koga Y., Akita Y., Nishioka J., Yatsuga S., Povalko N., Tanabe Y., et al. l-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005, 64:710-712.
4. Kubota M., Sakakihara Y., Mori M., Yamagata T., Momoi-Yoshida M. Beneficial effect of l-arginine for stroke-like episode in MELAS. Brain Dev 2004, 26:481-483.
5. Ohama E., Ohara S., Ikuta F., Tanaka K., Nishizawa M., Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987, 74:226-233.
6. Sakuta R., Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989, 25:594-601.
7. Mizukami K., Sasaki M., Suzuki T., Shiraishi H., Koizumi J., Ohkoshi N., et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol (Berl) 1992, 83:449-452.
8. Betts J., Jaros E., Perry R.H., Schaefer A.M., Taylor R.W., Abdel-All Z., et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurons and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006, 32:359-373.
9. Koga Y., Akita Y., Junko N., Yatsuga S., Povalko N., Fukiyama R., et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006, 66:1766-1769.
10. Takahashi N., Shimada T., Murakami Y., Katoh H., Oyake N., Ishibashi Y., et al. Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci 2005, 329:265-266.
11. Wilichowski E., Pouwels P.J., Frahm J., Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999, 30:256-263.
12. Molnár M.J., Valikovics A., Molnár S., Trón L., Diószeghy P., Mechler F., et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000, 55:544-548.
13. Nariai T., Ohno K., Ohta Y., Hirakawa K., Ishii K., Senda M. Discordance between cerebral oxygen and glucose metabolism, and hemodynamics in a mitochondrial encephalomyopathy, lactic acidosis, and strokelike episode patient. J Neuroimaging 2001, 11:325-329.
14. Iizuka T., Sakai F., Suzuki N., Hata T., Tsukahara S., Fukuda M., et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002, 59:816-824.
15. Iizuka T., Sakai F., Kan S., Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003, 61:1238-1244.
16. Iizuka T., Sakai F., Ide T., Miyakawa S., Sato M., Yoshii S. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS - implication of neurovascular cellular mechanism. J Neurol Sci 2007, 257:126-138.
17. Yoneda M., Maeda M., Kimura H., Fujii A., Katayama K., Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999, 53:2182-2184.
18. Oppenheim C., Galanaud D., Samson Y., Sahel M., Dormont D., Wechsler B., et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS?. J Neurol Neurosurg Psychiatry 2000, 69:248-250.
19. Yonemura K., Hasegawa Y., Kimura K., Minematsu K., Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. AJNR Am J Neuroradiol 2001, 22:269-272.
20. Ohshita T., Oka M., Imon Y., Watanabe C., Katayama S., Yamaguchi S., et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000, 42:651-656.
21. Kolb S.J., Costello F., Lee A.G., White M., Wong S., Schwartz E.D., et al. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 2003, 216:11-15.
22. Abe K., Yoshimura H., Tanaka H., Fujita N., Hikita T., Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004, 46:113-117.
23. Jian-Ren L. Precipitation of stroke-like event by chickenpox in a child with MELAS syndrome. Neurol India 2005, 53:323-325.
24. Ito H., Mori K., Harada M., Minato M., Naito E., Takeuchi M., et al. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev 2008, 30:483-488.
25. Alemdar M., Iseri P., Selekler M., Budak F., Demirci A., Komsuoglu S.S. MELAS presented with status epilepticus and Anton-Babinski syndrome; value of ADC mapping in MELAS. J Neuropsychiatry Clin Neurosci 2007, 19:482-483.
26. Ducreux D., Nasser G., Lacroix C., Adams D., Lasjaunias P. MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case. AJNR Am J Neuroradiol 2005, 26:1840-1844.
27. Wang X.Y., Noguchi K., Takashima S., Hayashi N., Ogawa S., Seto H. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology 2003, 45:640-643.
28. Tzoulis C., Bindoff L.A. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke 2009, 40:e15-e17.
29. Karkare S., Merchant S., Solomon G., Engel M., Kosofsky B. MELAS with A3243G mutation presenting with occipital status epilepticus. J Child Neurol 2009, 24:1564-1567.
30. Bi W.L., Baehring J.M., Lesser R.L. Evolution of brain imaging abnormalities in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol 2006, 26:251-256.
31. Mizrachi I.B., Gomez-Hassan D., Blaivas M., Trobe J.D. Pitfalls in the diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol 2006, 26:38-43.
32. Stoquart-Elsankari S., Lehmann P., Périn B., Gondry-Jouet C., Godefroy O. MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS. J Neurol 2008, 255:1593-1595.
33. Moller H.E., Kurlemann G., Putzler M., Wiedermann D., Hilbich T., Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci 2005, 229-230:131-139.
34. 1H MRS analysis. J Neurol Neurosurg Psychiatry 2001, 70:675-678.
35. Tsujikawa T., Yoneda M., Shimizu Y., Uematsu H., Toyooka M., Ikawa M., et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2010, 32:143-149.
36. Saneto R.P., Friedman S.D., Shaw D.W. Neuroimaging of mitochondrial disease. Mitochondrion 2008, 8:396-413.
37. Feng F., You H., Gao J., Li X.Z., Meng C.L., Sun H.Y., et al. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J 2006, 21:234-238.
38. Bianchi M.C., Sgandurra G., Tosetti M., Battini R., Cioni G. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep 2007, 27:69-85.
39. José da Rocha A., Túlio Braga F., Carlos Martins Maia A., Jorge da Silva C., Toyama C., Pereira Pinto Gama H., et al. Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J Neuroimaging 2008, 18:1-8.
40. Otsuki T., Kanamatsu T., Tsukada Y., Goto Y., Okamoto K., Watanabe H. Carbon 13-labeled magnetic resonance spectroscopy observation of cerebral glucose metabolism: metabolism in MELAS: case report. Arch Neurol 2005, 62:485-487.
41. Kaufmann P., Shungu D.C., Sano M.C., Jhung S., Engelstad K., Mitsis E., et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004, 62:1297-1302.
42. Möller H.E., Wiedermann D., Kurlemann G., Hilbich T., Schuierer G. Application of NMR spectroscopy to monitoring MELAS treatment: a case report. Muscle Nerve 2002, 25:593-600.
43. Pavlakis S.G., Kingsley P.B., Kaplan G.P., Stacpoole P.W., O'Shea M., Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998, 55:849-852.
44. Ikawa M., Okazawa H., Arakawa K., Kudo T., Kimura H., Fujibayashi Y., et al. PET imaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion 2009, 9:144-148.
45. Nishioka J., Akita Y., Yatsuga S., Katayama K., Matsuishi T., Ishibashi M., et al. Inappropriate intracranial hemodynamics in the natural course of MELAS. Brain Dev 2008, 30:100-105.
46. Thajeb P., Wu M.C., Shih B.F., Tzen C.Y., Chiang M.F., Yuan R.Y. Brain single photon emission computed tomography in patients with A3243G mutation in mitochondrial DNA tRNA. Ann NY Acad Sci 2005, 1042:48-54.
47. Peng N.J., Liu R.S., Li J.Y., Tsay D.G., Kong K.W., Kwok C.G., et al. Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT. Neuroradiology 2000, 42:26-29.
48. Miyamoto A., Oki J., Takahashi S., Itoh J., Kusunoki Y., Cho K. Serial imaging in MELAS. Neuroradiology 1997, 39:427-430.
49. Fujii T., Okuno T., Ito M., Hattori H., Mutoh K., Go T., et al. 123I-IMP SPECT findings in mitochondrial encephalomyopathies. Brain Dev 1995, 17:89-94.
50. Gropen T.I., Prohovnik I., Tatemichi T.K., Hirano M. Cerebral hyperemia in MELAS. Stroke 1994, 25:1873-1876.
51. Takahashi S., Tohgi H., Yonezawa H., Obara S., Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 1998, 158:58-64.
52. Sano M., Ishii K., Momose Y., Uchigata M., Senda M. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand 1995, 92:497-502.
53. Gerriets T., Stolz E., Walberer M., Muller C., Kluge A., Kaps M., et al. Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc 2004, 12:137-143.